Perrigo Company plc (NYSE:PRGO) Q2 2024 Earnings Conference Call August 2, 2024 8:30 AM ET

Company Participants

Bradley Joseph - Vice President of Global Investor Relations
Patrick Lockwood-Taylor - President & Chief Executive Officer
Eduardo Bezerra - Chief Financial Officer

Conference Call Participants

Chris Schott - JPMorgan
Korinne Wolfmeyer - Piper Sandler
Daniel Biolsi - Hedgeye

Operator

Good morning, ladies and gentlemen, and welcome to the Perrigo Second Quarter 2024 Financial Results Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Friday, August 2, 2024.

I would now like to turn the conference over to Bradley Joseph Vice President of Global Investor Relations. Please go ahead.

Bradley Joseph

Good morning, and good afternoon, everyone. Welcome to Perrigo's second quarter 2024 earnings conference call. I hope you all had a chance to review our press release issued today. A copy of the release and presentation for today's discussion are available within the Investors section of the perrigo.com website. Joining today's call are President and CEO, Patrick Lockwood-Taylor; and CFO, Eduardo Bezerra.

I would like to remind everyone that during this call, participants will make certain forward-looking statements. Please refer to the important information for shareholders and investors and safe harbor language regarding these statements in our release issued earlier today.

A few items before we start. First, unless otherwise stated, all financial results discussed and presented are on a continuing operations basis. Continuing operations include the HRA Rare Diseases business, which was classified as held for sale after the quarter end and does not include any contributions from the divested RX business, which was accounted for as discontinued operations prior to its sale.

Second, organic growth excludes acquisitions, divestitures, exited product lines and currency in both comparable periods. All comments related to constant currency removed the impact of currency translation versus the prior year by applying the exchange rates used in the comparable measurement in the prior year's financial statements.

And third, Patrick's discussion will focus solely on non-GAAP results, except as otherwise noted. See the appendix for additional details and reconciliations of all non-GAAP financial measures presented.

And with that, I'm pleased to turn the call to Patrick.

Patrick Lockwood-Taylor

Thank you, Brad. Good morning, good afternoon, everyone. So to begin today's call, I'd like to briefly reflect on my first 12 months as CEO, and the significant strides our team has made to advance our One Perrigo vision.